French breast implant maker faced US lawsuits

December 26, 2011 in Other

Breast implants made by troubled French firm PIP have been at the heart of multiple lawsuits in the United States, where they were sold up until 2000, documents filed with the US government show.

Tens of thousands of women worldwide have been fitted with the implants, which were made from industrial rather than medical grade silicone.

France's health ministry recommended last week that the 30,000 women in the country with the implants have them taken out, saying that while there is no proven cancer risk, they could rupture dangerously.

In the United States, PIP implants were sold through Heritage Worldwide until May 2000, when the US launched a moratorium on .

At the time, the US market accounted for 40 percent of Heritage Worldwide's revenues, or $4 million, according to corporate documents filed in 2009 with the US .

The firm posted significant losses in subsequent years, especially starting in 2007, as both users and distributors filed complaints against the company.

Between 1996 and 2009, PIP was the of several dozen lawsuits in the United States, filed not only by women using the implants but also by its business partners, claiming breach of contract or unmet payments.

A February 2009 document cites three complaints in Florida -- filed in October 1999, June 2000 and July 2003 by five members of the Kwartin family against PIP, its affiliates and founder Jean-Claude Mas.

The plaintiffs said they were shareholders of PIP distributor PIP/USA, Inc. and were seeking unspecified damages from PIP and other stakeholders "arising out of alleged tortious and other purported wrongful acts," the document added.

The complaints were later consolidated into a in 2005.

Dozens of women began filing lawsuits against PIP, mainly for product liability, starting in 2003, including in Illinois and Texas. But as of 2009, no trial date had yet been set. Many of the lawsuits were later dismissed.

The complaints cited defective merchandise not suited for its intended purpose and violations of local consumer legislation.

PIP was once the world's third-largest producer of silicone implants.

(c) 2011 AFP

3.4 /5 (7 votes)  

Rank 3.4 /5 (7 votes)
Related Stories
Relevant PhysicsForums posts

More news stories

ACP issues recommendations for management of high blood glucose in hospitalized patients

High blood glucose is associated with poor outcomes in hospitalized patients, and use of intensive insulin therapy (IIT) to control hyperglycemia is a common practice in hospitals. But the recent evidence does not show a ...

Other created 18 hours ago | popularity not rated yet | comments 0

Future doctors unaware of their obesity bias

Two out of five medical students have an unconscious bias against obese people, according to a new study by researchers at Wake Forest Baptist Medical Center. The study is published online ahead of print in the Journal of ...

Other created May 23, 2013 | popularity not rated yet | comments 0

Plastic realistic: Medical students to use plastinated human bodies for anatomy learning

Nanyang Technological University's (NTU) new medical school will be pioneering the use of plastinated bodies for medical education in Singapore.

Other created May 23, 2013 | popularity not rated yet | comments 0

Survey points out deficiencies in addictions training for medical residents

A 2012 survey of internal medicine residents at Massachusetts General Hospital (MGH) – one of the nation's leading teaching hospitals – found that more than half rated the training they had received in addiction and other ...

Other created May 22, 2013 | popularity 5 / 5 (1) | comments 0

Early use of tracheostomy for mechanically ventilated patients not associated with improved survival

For critically ill patients receiving mechanical ventilation, early tracheostomy (within the first 4 days after admission) was not associated with an improvement in the risk of death within 30 days compared to patients who ...

Other created May 21, 2013 | popularity not rated yet | comments 0


Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Engineered cytomegalovirus protects monkeys from HIV equivalent

(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...

Driving and hands-free talking lead to spike in errors, study shows

Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Pollen count apps for smartphones are nothing to sneeze at

Kate O'Reilly's spring allergy survival kit includes the usual stuff - nasal sprays, allergy pills and a box of tissues. This season, she's added a new weapon to her line of defense: an app on her smartphone.